Delivery Order SPE2DB22D1200-SPE2DB24FN2VV
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,047.52 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award, valued at $1,651.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Olmesartan Medoxomil 40 mg tablets in 90-count packages. The contract has a period of performance through February 20, 2024 and is a Firm Fixed Price Delivery Order. This award was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,965.23 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets in 90-count bottles. The contract has an ultimate completion date of April 9, 2024 and was awarded on April 8, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,821.70 Firm Fixed Price Delivery Order contract is for the supply of Olmesartan Medoxomil 40 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,564.55 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,545.34 firm fixed-price delivery order is for Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,703.97 Firm Fixed Price Delivery Order is for the supply of Olmesartan Medoxomil 40 mg tablets. The contract has an ultimate completion date of December 7, 2023 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,722.49 Delivery Order contract is for the supply of Olmesartan Medoxomil 40 mg tablets. The award is a child contract under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award, valued at $10,367.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,149.84 firm-fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB24FN2VVDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,181.98 firm fixed-price delivery order is for the supply of Olmesartan Medoxomil 40 mg tablets in 90-count packages. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 5/31/24 |